根据美国证券交易委员会（SEC）最新披露的文件，Matinas BioPharma Holdings, Inc（简称：MTNB）宣布其首席财务官基思·库辛斯基（Keith Kucinski）已提交辞呈，卸任生效日期定为2026年1月17日。
该文件显示，库辛斯基的离职属于个人职业规划调整，公司高层对其在职期间的贡献表示认可，并已启动新任首席财务官的遴选程序。Matinas BioPharma Holdings, Inc 强调，此次人事变动不会影响公司现有财务战略及日常运营的稳定性。
作为一家专注于创新疗法开发的生物制药企业，Matinas BioPharma Holdings, Inc 将持续推进其管线药物的研发进程，管理层变动细节将依据监管要求适时对外公布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.